"Because we are in a health care setting, masks are still required in all facilities. Thank you for helping keep our patients and staff safe."

During the past decade, Cancer Care and Hematology-Fort Collins conducted 53 clinical trials. In the 10-year time frame, 53 clinical trials started and 1 clinical trials were completed, i.e. on average, 1.9% percent of trials that started reached the finish line to date. In the past 5 years, 38 clinical trials started and 1 clinical trials were completed. i.e. 2.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Cancer Care and Hematology-Fort Collins" #1 sponsor was "National Cancer Institute (NCI)" with 28 trials, followed by "NRG Oncology" with 7 trials sponsored, "SWOG Cancer Research Network" with 7 trials sponsored, "Alliance for Clinical Trials in Oncology" with 4 trials sponsored and "ECOG-ACRIN Cancer Research Group" with 4 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Cancer Care and Hematology-Fort Collins" #1 collaborator was "National Cancer Institute (NCI)" with 23 trials as a collaborator, "NRG Oncology" with 9 trials as a collaborator, "Canadian Cancer Trials Group" with 4 trials as a collaborator, "Division of Cancer Control" with 1 trials as a collaborator and "NIH Biomarker, Imaging and Quality of Life Studies Funding Program (BIQSFP)" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Cancer Care and Hematology-Fort Collins" are "Stage IV Lung Cancer AJCC v8" (6 trials), "Extensive Stage Lung Small Cell Carcinoma" (4 trials), "Colon Adenocarcinoma" (3 trials), "Invasive Breast Carcinoma" (3 trials) and "Prostate Adenocarcinoma" (3 trials). Many other conditions were trialed in "Cancer Care and Hematology-Fort Collins" in a lesser frequency.

Most popular intervention types in "Cancer Care and Hematology-Fort Collins" are "Drug" (45 trials), "Other" (29 trials), "Procedure" (26 trials), "Biological" (24 trials) and "Radiation" (17 trials). Other intervention types were less common.

The name of intervention was led by "Quality-of-Life Assessment" (20 trials), "Biospecimen Collection" (17 trials), "Computed Tomography" (16 trials), "Questionnaire Administration" (15 trials) and "Magnetic Resonance Imaging" (14 trials). Other intervention names were less common.

The vast majority of trials in "Cancer Care and Hematology-Fort Collins" are 44 trials for "All" genders, 5 trials for "Male" genders and 4 trials for "Female" genders.

Currently, there are NaN active trials in "Cancer Care and Hematology-Fort Collins". undefined are not yet recruiting, 33 are recruiting, 17 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Cancer Care and Hematology-Fort Collins, 2 suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Cancer Care and Hematology-Fort Collins, 2 "Phase 1" clinical trials were conducted, 28 "Phase 2" clinical trials and 30 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".